default_top_notch
default_news_top
default_news_ad1
default_nd_ad1

Medipost, LG Chem to develop stem cell therapy

Lee Han-soo  Published 2019.01.08  17:55  Updated 2019.01.08 17:55

공유
default_news_ad2

Medipost said Monday that it has signed a cooperation agreement with LG Chem for developing gene stem cell therapy.

Under the accord, the two companies will conduct research to find a stem cell drug candidate for the next two years.

Medipost will be responsible for developing and delivering umbilical cord blood-derived mesenchymal stem cells, while LG Chem will take charge in selecting the genes that cause disease and stem cell generation using genetic engineering techniques.

"Through this joint research, we will be able to utilize LG Chem's excellent gene search and infusion ability and development know-how in the development of therapeutic drugs," a Medipost company official said. "We will develop a treatment that will reduce the burden on patients with the aim of removing the root cause of the disease."

corea022@docdocdoc.co.kr

<© KBR , All rights reserved.>
default_news_ad5
default_news_bottom
default_nd_ad4
default_bottom
#top
default_bottom_notch